MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-MH-27-0034982
Cynor Pharma Private Limited
Cynor Pharma Private Limited - pharma in Panvel, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹3.21 Cr
▲ 107% YoY
Net profit · FY 2025
₹15.82 Lakh
Net margin 4.9%
EBITDA · FY 2025
₹15.82 Lakh
EBITDA margin 4.9%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Cynor Pharma Private Limited
Data last updated:
Cynor Pharma Private Limited is a private limited company based in Panvel, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 December 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2017PTC303411. Its GSTIN is 27AAHCC3411H1ZY (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Manseer Ashiq Yoosaf and Amjad Ansari Ali.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No 15 Grd Floor Plot No 157 / 160 Triveni Apartment Sector 19 Kharghar, Panvel, Maharashtra, India – 410210.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.21 Cr, a growth of 107% compared to the previous year. For the same year it recorded a net profit of ₹15.82 Lakh (net margin 4.9%) and EBITDA of ₹15.82 Lakh (EBITDA margin 4.9%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years.
Cynor Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-27-0034982). The current compliance status is marked as compliant by the Registrar of Companies.
Company Details of Cynor Pharma Private Limited
CIN U74999MH2017PTC303411
Registration Number 303411
Incorporation Date 28 December 2017
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-27-0034982
Recognitions & Rankings of Cynor Pharma
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressShop No 15 Grd Floor Plot No 157 / 160 Triveni Apartment Sector 19 Kharghar, Panvel, Maharashtra, India – 410210
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Cynor Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity
The main business activity of Cynor Pharma is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Financials of Cynor Pharma Private Limited
FY 2025 filings availableCynor Pharma Private Limited reported revenue of ₹3.21 Cr (up 107% YoY) for FY 2025.
Revenue · FY 2025
₹3.21 Cr ▲ 107%
Net profit · FY 2025
₹15.82 Lakh margin 4.9%
EBITDA · FY 2025
₹15.82 Lakh margin 4.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 107%
3 years · compounded
▲ 18%
EBITDA CAGR growth
1 year
▲ 102%
3 years · compounded
▲ 57%
5 years · compounded
▲ 131%
Revenue has grown at a compounded annual rate (CAGR) of 18% over three years, including 107% growth in the latest year. EBITDA rose 102% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2020-21 to FY 2023-24in the company report |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | |
| Other Income | •••• | |
| Total Revenue | •••• | |
| Cost of Materials Consumed | •••• | |
| Employee Benefit Expense | •••• | |
| Finance Costs | •••• | |
| Depreciation and Amortisation | •••• | |
| Other Expenses | •••• | |
| Total Expenses | •••• | |
| EBITDA | ₹15.82 Lakh | |
| Profit Before Tax | •••• | |
| Tax Expense | •••• | |
| Net Profit (PAT) | ₹15.82 Lakh | |
| Balance Sheet | ||
| Share Capital | •••• | |
| Reserves and Surplus | •••• | |
| Net Worth (Total Equity) | •••• | |
| Long-term Borrowings | •••• | |
| Short-term Borrowings | •••• | |
| Trade Payables | •••• | |
| Total Liabilities | •••• | |
| Fixed Assets | •••• | |
| Investments | •••• | |
| Inventories | •••• | |
| Trade Receivables | •••• | |
| Cash and Bank Balance | •••• | |
| Total Assets | •••• | |
Financial Ratios
| Metrics | FY 2024-25 | FY 2020-21 to FY 2023-24in the company report |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 4.9% | |
| Net Profit Margin | 4.9% | |
| Return on Equity (ROE) | •••• | |
| Return on Capital Employed (ROCE) | •••• | |
| Return on Assets (ROA) | •••• | |
| Liquidity and Debt | ||
| Current Ratio | •••• | |
| Quick Ratio | •••• | |
| Debt-to-Equity Ratio | •••• | |
| Interest Coverage Ratio | •••• | |
| Efficiency and Growth | ||
| Asset Turnover | •••• | |
| Receivable Days | •••• | |
| Payable Days | •••• | |
| Inventory Days | •••• | |
| Revenue Growth | •••• | |
| Net Profit Growth | •••• | |
Paid data: the figures shown as dots, and every line for FY 2020-21 to FY 2023-24, are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Cynor Pharma are in the company report.
: available in the company report
Board of Directors of Cynor Pharma Private Limited
Cynor Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manseer Ashiq Yoosaf | Director | 07 Apr 2022 | 4 Years 6 Months | Current |
| Amjad Ansari Ali Also directs: Larksois Pharma Private Limited | Director | 28 Dec 2017 | 8 Years 9 Months | Current |
Peer Comparison
Cynor Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (other hospital and medical care activities). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Amazeal Life Science Private Limited | ₹3.21 Cr (FY 2024) | •••• | •••• | 37.0% | •••• | Kolkata, West Bengal, India |
| Cynor Pharma Private Limited this company | ₹3.21 Cr (FY 2025) | •••• | •••• | 107.0% | •••• | Panvel, Maharashtra, India |
| Nessmed Healthcare Private Limited | ₹3.21 Cr (FY 2024) | •••• | •••• | 48.0% | •••• | Delhi, India |
| Asha Medicare Private Limited | ₹3.21 Cr (FY 2025) | •••• | •••• | 47.0% | •••• | Nagpur, Maharashtra, India |
Peers are the companies nearest to Cynor Pharma by revenue, above and below it, in the Pharma industry (Formulations), with the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details
Cynor Pharma Private Limited is audited by NIRUPA JETHWA & CO for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| NIRUPA JETHWA & CO | Locked | Locked | Locked |
: available in the company report
Ownership and Shareholding
: available in the company report
Charges & Borrowings
Cynor Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance
Employment history and EPFO contributions of people linked to Cynor Pharma.
: available in the company report
Recent Activity
Cynor Pharma Private Limited has 5 board changes on record since 2017: 2 appointments and 3 cessations. The latest: Jagdish Hardas Hemrajani ceased to be Director on 07 Apr 2022.
AGM
Cynor Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Cynor Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Jagdish Hardas Hemrajani ceased to be Director.
Appointed
Manseer Ashiq Yoosaf was appointed as Director.
Ceased
Shaukat Faruqui ceased to be Director.
Ceased
Saud Abdul Rehman Khalifa ceased to be Director.
Appointed
Amjad Ansari Ali was appointed as Director.
Incorporation
28 Dec 2017
Cynor Pharma Private Limited was registered on 28 Dec 2017 with Roc Mumbai & aged 8 years 9 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts
: available in the company report
MSME Payment Delays
: available in the company report
Subsidiaries & Group Companies
: available in the company report
GST Compliance
Cynor Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCC3411H1ZY | Maharashtra | Active | 16 Feb 2018 |
: available in the company report
MCA Filings & Documents
: available in the company report
Frequently Asked Questions
Cynor Pharma is an active private limited company based in Panvel, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 28 December 2017 (9+ years old) and is registered under CIN U74999MH2017PTC303411.
Cynor Pharma has 2 current directors:
- Manseer Ashiq Yoosaf - Director
- Amjad Ansari Ali - Director
The latest financial statements of Cynor Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Cynor Pharma is 27AAHCC3411H1ZY, registered in Maharashtra.
The CIN (Corporate Identification Number) of Cynor Pharma is U74999MH2017PTC303411. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cynor Pharma was incorporated on 28 December 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Cynor Pharma by revenue are Amazeal Life Science Private Limited, Nessmed Healthcare Private Limited, Asha Medicare Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (other hospital and medical care activities).
Jagdish Hardas Hemrajani ceased to be Director on 07 Apr 2022. Manseer Ashiq Yoosaf was appointed as Director on 07 Apr 2022. Shaukat Faruqui ceased to be Director on 07 Apr 2022. Cynor Pharma has 5 board changes on record in total.
Yes, Cynor Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-27-0034982).
The registered office of Cynor Pharma is at Shop No 15 Grd Floor Plot No 157 160 Triveni Apartment Sector 19 Kharghar, Panvel, Maharashtra, India – 410210.
Cynor Pharma operates in the pharma industry, in the drug formulation and development segment.